Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioceres Crop Solutions (BIOX) Notes Payables (2017 - 2025)

Historic Notes Payables for Bioceres Crop Solutions (BIOX) over the last 9 years, with Q3 2025 value amounting to $85.1 million.

  • Bioceres Crop Solutions' Notes Payables fell 2974.49% to $85.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $85.1 million, marking a year-over-year decrease of 2974.49%. This contributed to the annual value of $119.7 million for FY2025, which is 1244.56% down from last year.
  • Latest data reveals that Bioceres Crop Solutions reported Notes Payables of $85.1 million as of Q3 2025, which was down 2974.49% from $119.7 million recorded in Q2 2025.
  • Bioceres Crop Solutions' Notes Payables' 5-year high stood at $142.6 million during Q1 2024, with a 5-year trough of $66.7 million in Q3 2021.
  • Over the past 5 years, Bioceres Crop Solutions' median Notes Payables value was $105.5 million (recorded in 2022), while the average stood at $102.2 million.
  • In the last 5 years, Bioceres Crop Solutions' Notes Payables surged by 5096.42% in 2023 and then plummeted by 3293.29% in 2025.
  • Bioceres Crop Solutions' Notes Payables (Quarter) stood at $90.7 million in 2021, then rose by 16.27% to $105.5 million in 2022, then grew by 7.58% to $113.5 million in 2023, then increased by 5.01% to $119.2 million in 2024, then fell by 28.57% to $85.1 million in 2025.
  • Its Notes Payables stands at $85.1 million for Q3 2025, versus $119.7 million for Q2 2025 and $95.6 million for Q1 2025.